Wilfredo Pagani, MD
Gastroenterology · San Juan, PRNPI 1477630127
Payments from drug & device makers
Across 17 payments — averaging $81.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$271
- Gilead$179
- Olympus Latin America, Inc.$147
- Madrigal Pharmaceuticals$144
- Takeda Pharmaceuticals U.S.A., Inc.$143
- Pfizer Pharmaceuticals LLC$125
- plus $376 from 5 others
What the payments were for
- Food & beverage$1,37799%
- Education$81%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $271 |
| Gilead | 3 | $179 |
| Olympus Latin America, Inc. | 1 | $147 |
| Madrigal Pharmaceuticals | 1 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $143 |
| Pfizer Pharmaceuticals LLC | 1 | $125 |
| Sanofi | 1 | $125 |
| Merck | 1 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $95 |
| Boston Scientific | 1 | $50 |
| Pfizer | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,385 in reported general payments places this provider in the 45th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuprepSodium, Potassium,mag Sulfates | 78 | $9,188 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 81 | $6,473 |
| Famotidine | 163 | $1,334 |
| Omeprazole | 108 | $791 |
| Pantoprazole Sodium | 53 | $530 |
| Flumazenil | 54 | $455 |
| Esomeprazole Magnesium | 13 | $282 |
| Midazolam HclMidazolam Hcl/Pf | 73 | $242 |
| Dicyclomine Hcl | 11 | $172 |
| Midazolam Hcl | 39 | $143 |
| Fentanyl CitrateFentanyl Citrate/Pf | 41 | $141 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Juan
- Marcia Cruz CorreaSan Juan$12.4M
- Jose Rivera-AcostaSan Juan$882K
- Esther TorresSan Juan$493K
- Melvyn AcostaSan Juan$358K
- Melvin Melendez RiosSan Juan$129K
- Loscar SantiagoSan Juan$65K
- Henry Gonzalez RiveraSan Juan$34K
- Jose Munoz AcabaSan Juan$28K
- Hector LozanoSan Juan$28K
- Doris ToroSan Juan$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.